Publication | Open Access
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
189
Citations
37
References
2015
Year
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints which may have rapid translational potential as a novel immunotherapeutic agent.
| Year | Citations | |
|---|---|---|
Page 1
Page 1